Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Nephrology
Cardiology and CTVS
Medicine
Empagliflozin Reduces Cardiac And Renal Risk In HFrEF Patients, Regardless Of Baseline NT-ProBNP: Study
0 Comments
Post a comment
No comments yet. Be the first to comment!